Sign in
8-K

Current Report

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213900-20-015712

Bylaws or fiscal year change · Shareholder vote results

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea123419-8k_elitepharma.htm…